Search for European Projects

16 European Projects Found

Searched on 125080 European Projects

 FINISHED 

European Virus Archive goes global (EVAg)

Start date: Apr 1, 2015, End date: Mar 31, 2019,

The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of institutes selected for their appropriate expertises, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The network of EVAg laboratories including 25 institutions represents an extensive range o ...
Read Project

 27

 FINISHED 

Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine (EbolaVac)

Start date: Oct 7, 2014, End date: Oct 6, 2017,

The first Ebolavirus Zaire (EBOV) outbreak of 2014 was declared on 22 March in Guinea. As of 30 September 2014, the World Health Organization (WHO) reports the total number of cases in the current outbreak of Ebola virus disease (EVD) in West Africa at 7470, with 3431 deaths. The US Centers for Disease Control and Prevention states that the number of cases is currently doubling every 20 days and e ...
Read Project

 5

 FINISHED 

European Research Infrastructure on Highly Pathogenic Agents 2 (ERINHA2)

Start date: Jan 1, 2016, End date: Jun 30, 2017,

ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary ...
Read Project

 17

 FINISHED 

New Medicines for Trypanosomatidic Infections (NMTRYPI)

Start date: Feb 1, 2014, End date: Jan 31, 2017,

The infectious diseases burden imposed by the parasites of Trypanosomatidae family represents a huge problem on people’s lives in countries where these diseases are endemic. Problems associated with existing drugs include inefficient delivery, insufficient efficacy, excessive toxicity and increasing resistance. New drugs are urgently needed now and in the foreseeable future. The New Medicine for T ...
Read Project

 14

 FINISHED 

Dengue research Framework for Resisting Epidemics in Europe (DENFREE)

Start date: Jan 1, 2012, End date: Dec 31, 2016,

"WHO estimates that one of the main consequences of global warming will be an increased burden of vector-borne diseases. Among these, dengue appears to be particularly problematic, with tens of millions of cases of dengue fever estimated to occur annually, including up to 500,000 cases of the life-threatening dengue hemorrhagic fever/dengue shock syndrome. In recent years, the global burden of den ...
Read Project

 15

 FINISHED 

Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans (REACTION)

Start date: Nov 1, 2014, End date: Oct 31, 2016,

The ongoing Ebola outbreak in West Africa is the largest and deadliest the world has ever seen. In September 2014, the number of EBOV cases exceeded the total of all cases from previous known outbreaks. Further, this public health crisis shifted into a complex emergency, with significant, social, economic, humanitarian, political and security dimensions. Till date, no effective medicine has been p ...
Read Project

 14

 FINISHED 

Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR) (EVIMalaR)

Start date: Oct 1, 2009, End date: Mar 31, 2015,

This is a proposal from 55 partners from 36 institutes to form a NoE that will seek to integrate European malaria research that is directed towards a better understanding of the basic biology of the parasite, its vector and of the biology of the interactions between the parasite and both its mammalian host and vectors. All the member institutes and researchers have demonstrated both their excellen ...
Read Project

 40

 FINISHED 

European Virus Archive (EVA)

Start date: Jan 1, 2009, End date: Dec 31, 2014,

"During the past 70 years or more, thousands of viruses have been isolated and partly characterised by experts working in different countries worldwide. These viruses potentially provide a unique and extremely valuable medical and educational resource for research and development to understand the basis of virus diseases, and to develop modern state of the art strategies for disease control. Howev ...
Read Project

 11

 FINISHED 

African Programme for Advanced Research Epidemiology Training (APARET)

Start date: Apr 1, 2011, End date: Dec 31, 2014,

The APARET fellowship programme will catalyse independent research activities of graduates of Field Epidemiology Training Programmes (FETP) and Field Epidemiology Laboratory Training programmes (FELTP) in Africa. APARET fellows will be employed as research associates by African APARET partners for 2 years (salary provided by host institute). During the first year of their contract they will be emb ...
Read Project

 13

 FINISHED 

TOWARDS THE ESTABLISHMENT OF A FRAMEWORK IN MALARIA BETWEEN THE AMRN AND EVIMALAR (Ozmalnet)

Start date: Jan 1, 2012, End date: Dec 31, 2014,

54 partners from 34 institutes have formed an EC-funded Network of Excellence (NoE) in basic malaria research, the European Virtual Institute for Malaria Research (EVIMalaR). Over the previous >5 years as the NoE Biomalpar these partners successfully broke down many barriers to cooperation pursuing a programme of integrated research. This was greatly assisted by the Biomalpar PhD School whose stud ...
Read Project

 14

 FINISHED 

Improvement of current and development of new vaccines for theileriosis and babesios of small ruminants (PIROVAC)

Start date: Apr 1, 2010, End date: Sep 30, 2014,

The proposal deals with the establishment of control measures for two major tick-borne diseases of small ruminants: theileriosis caused by Theileria lestoquardi and T. uilenbergi and babesiosis caused by Babesia ovis. The research programme aims at improving existing and producing new attenuated vaccines, designing subunit vaccines and capability building. To achieve these goals the proposal will ...
Read Project

 15

 FINISHED 

European Research Infrastructure on Highly Pathogenic Agents (ERINHA)

Start date: Nov 1, 2010, End date: Aug 31, 2014,

In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be well-prepared to face such threats. However, the Biosafety Level 4 (BSL4) capacity in Europe is not sufficient enough to cover the efficient development of diagnosis, prophylactic and therapeutics means against these pathogens. Moreover, there is no global co ...
Read Project

 27

 FINISHED 

Identification and development of vaccine candidates for Buruli Ulcer Disease (BuruliVac)

Start date: Mar 1, 2010, End date: May 31, 2013,

Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, is a neglected bacterial infection of the poor in remote rural areas, mostly affecting children. BUD, the third most common mycobacterial disease in immunocompetent humans after tuberculosis and leprosy, is most endemic in West Africa, but cases have been reported from more than 30 countries. BUD is a mutilating disease leading to sever ...
Read Project

 16

 FINISHED 

Signalling in life cycle stages of malaria parasites (MALSIG)

Start date: Feb 1, 2009, End date: Jul 31, 2012,

Malaria is a major public health problem in the developing world and is endemic in many regions of India. The development of novel strategies for malaria control requires a better understanding of the biology of malaria parasites. Our project aims at bringing a significant contribution to this field, through dissecting the signalling pathways that regulate essential processes in the life cycle o ...
Read Project

 18

 FINISHED 

Molecular and serological techniques to study Lassa virus ecology (ECOLASSA)

Start date: May 1, 2010, End date: Apr 30, 2012,

"Lassa fever is a zoonotic disease caused by Lassa virus. The disease is endemic in West Africa. Hemorrhagic courses of Lassa fever are associated with high mortality. It is estimated that 100,000 to 500,000 infections occur each year because of transmission of Lassa virus from its rodent reservoir (Mastomys natalensis) to human. Rodent control measures could reduce the risk of rodent-human transm ...
Read Project

 1

 FINISHED 

Genetic Analysis of the host-pathogen interaction in tuberculosis (TB-EURO-GEN)

Start date: Mar 1, 2008, End date: Aug 31, 2011,

"We propose to extend an existing collection of DNA extracts from TB patients and their corresponding TB DNA to establish the world’s largest resource of extracts from a population of TB patients and 5000 ethnically matched healthly controls. The bank will comprise 5000 DNA host DNA extracts paired the DNA and cultures of the strain of Mycobacterium tuberculosis causing their disease. We will pe ...
Read Project

 5